Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

IRW-PRESS: ACCESS Newswire: Eastman, AstraZeneca, Kraft Heinz und P&G mit OMP Supply Chain Awards ausgezeichnetMIAMI, FLORIDA / ACCESS Newswire /…

AstraZeneca’s Saphnelo approved in EU for self-administration in lupus…

Astrazeneca (AZN) closed the most recent trading day at $91.56, moving +1.93% from the previous trading session.…

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for…

JPMorgan has put AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) at the top of its UK healthcare picks for 2026, arguing that the company…

JPMorgan has put AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) at the top of its UK healthcare picks for 2026, arguing that the company…

NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat das Kursziel für Novartis von 95 auf 125 Franken angehoben…

AZN and MRK boast major oncology strengths and expanding pipelines amid shifting market dynamics in this pharma matchup.…

Pharma companies are facing pricing pressure from several directions, including from the U.S. Medicare negotiations…

The company is wasting little time figuring out the particulars of a sweeping capital investment program.…

AstraZeneca is investing $2 billion in manufacturing in Maryland that will support 2,600 jobs, state and company officials announced Friday.…

AstraZeneca to invest $2 billion expanding Maryland manufacturing sites…

AstraZeneca said on Friday it will invest $2 billion to expand its manufacturing footprint in Maryland as part of its…

Welcome to this weeks Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please submit the…

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…

FTSE 100 hits record high as job market data weakens pound; AstraZeneca shines…

Image source: The Motley Fool.DATEThursday, Nov. 6, 2025 at 4:30 p.m. ETCALL PARTICIPANTSPresident and Chief Executive Officer — Dr. David…

AstraZeneca posts strong Q3 results. Core earnings and revenues beat estimates as key drugs like Tagrisso, Imfinzi and Farxiga fuel…

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) posted what analysts called a very solid set of third-quarter results, but the shares barely moved in…

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) posted what analysts called a very solid set of third-quarter results, where guidance was maintained and the…